Quantification of methylone and metabolites in rat and human plasma by liquid chromatography-tandem mass spectrometry

被引:8
|
作者
Ellefsen, Kayla N. [1 ,2 ]
Concheiro, Marta [1 ]
Suzuki, Masaki [3 ,4 ]
Rice, Kenner C. [3 ,4 ]
Elmore, Joshua S. [5 ]
Baumann, Michael H. [5 ]
Huestis, Marilyn A. [1 ]
机构
[1] NIDA, Chem & Drug Metab, Intramural Res Program, NIH, Baltimore, MD 21224 USA
[2] Univ Maryland, Toxicol Program, Baltimore, MD 21201 USA
[3] NIDA, Drug Design & Synth Sect, Intramural Res Program, Baltimore, MD 21224 USA
[4] NIAAA, NIH, Baltimore, MD USA
[5] NIDA, Designer Drug Res Unit, Intramural Res Program, NIH, Baltimore, MD 21224 USA
基金
美国国家卫生研究院;
关键词
Methylone; Synthetic cathinones; Novel designer drugs; Metabolites; 4-Hydroxy-3-methoxymethcathinone; LC-MS/MS; SYNTHETIC CATHINONES; DESIGNER DRUG; BATH SALTS; MEPHEDRONE; MDPV;
D O I
10.1007/s11419-015-0263-z
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Methylone is a commonly abused synthetic cathinone derivative marketed as a "legal" alternative to "ecstasy" or cocaine. Previous studies examined the metabolism of methylone in vitro and in vivo; 4-hydroxy-3-methoxymethcathinone (HMMC) was identified as the primary metabolite, with other reported minor metabolites, 3,4-methylenedioxycathinone (MDC) and 3,4-dihydroxymethcathinone (HHMC). However, limited information is known about methylone and its metabolites' pharmacokinetics. We developed and fully validated a method for the simultaneous quantification of methylone, HMMC, MDC and HHMC by liquid chromatography-tandem mass spectrometry in 100 A mu l rat and human plasma. beta-Glucuronidase was utilized for plasma hydrolysis, followed by perchloric acid protein precipitation and solid-phase extraction utilizing cation exchange columns. Chromatographic separation was performed with a Synergi Polar column in gradient mode, and analytes were determined by two multiple reaction monitoring (MRM) transitions. Linear ranges of 0.5-1,000 A mu g/l (methylone, HMMC and MDC) and 10-1,000 A mu g/l (HHMC) were achieved. Bias and imprecision were generally acceptable, although quantification of HHMC exhibited variability (16.2-37 %). Extraction efficiencies and ion suppression were 89.9-104 % (for HHMC, 15.9-16.2 %) and < 11.4 %, respectively. Methylone and metabolites were stable in plasma for 24 h at room temperature, 72 h at 4 A degrees C, and after three freeze-thaw cycles (except for a 60 % HMMC increase). Human and rat plasma were cross-validated, documenting that rat plasma quality control samples were accurately quantified against a human plasma calibration curve (-23.8 to 12 % bias). As proof of method, rat plasma specimens were analyzed pre-injection and after subcutaneous administration of methylone at 6 mg/kg from 15 to 480 min post-dosing. Methylone, HMMC, MDC and HHMC concentrations ranged from 1.1 to 1,310, 11.2 to 194, 1.9 to 152 and 24.7 to 188 A mu g/l, respectively.
引用
收藏
页码:202 / 212
页数:11
相关论文
共 50 条
  • [1] Quantification of methylone and metabolites in rat and human plasma by liquid chromatography-tandem mass spectrometry
    Kayla N. Ellefsen
    Marta Concheiro
    Masaki Suzuki
    Kenner C. Rice
    Joshua S. Elmore
    Michael H. Baumann
    Marilyn A. Huestis
    [J]. Forensic Toxicology, 2015, 33 : 202 - 212
  • [2] Multiplexed quantification of venlafaxine and metabolites in human plasma by liquid chromatography-tandem mass spectrometry
    Pandey, Aashish
    Price, Amelia
    Ayala-Lopez, Nadia
    Garza, Kyana Y.
    Marzinke, Mark A.
    Knezevic, Claire E.
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2024, 243
  • [3] Liquid Chromatography-tandem Mass Spectrometry for Quantification of Dioscin in Rat Plasma
    Kong, Tae Yeon
    Ji, Hye Young
    Choi, Sang-Zin
    Son, Miwon
    Lee, Hye Suk
    [J]. MASS SPECTROMETRY LETTERS, 2013, 4 (03) : 55 - 58
  • [4] Quantification of rabeprazole in human plasma by liquid chromatography-tandem mass spectrometry
    Zhang, Y
    Chen, XY
    Gu, Q
    Zhong, DF
    [J]. ANALYTICA CHIMICA ACTA, 2004, 523 (02) : 171 - 175
  • [5] Quantification of micafungin in human plasma by liquid chromatography-tandem mass spectrometry
    Giuliana Cangemi
    Sebastiano Barco
    Roberto Bandettini
    Elio Castagnola
    [J]. Analytical and Bioanalytical Chemistry, 2014, 406 : 1795 - 1798
  • [6] Quantification of micafungin in human plasma by liquid chromatography-tandem mass spectrometry
    Cangemi, Giuliana
    Barco, Sebastiano
    Bandettini, Roberto
    Castagnola, Elio
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2014, 406 (06) : 1795 - 1798
  • [7] Simultaneous quantification of nicotine and metabolites in rat brain by liquid chromatography-tandem mass spectrometry
    Vieira-Brock, Paula L.
    Miller, Eleanor I.
    Nielsen, Shannon M.
    Fleckenstein, Annette E.
    Wilkins, Diana G.
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2011, 879 (30): : 3465 - 3474
  • [8] Quantification of clenbuterol in human plasma and urine by liquid chromatography-tandem mass spectrometry
    Thevis, M
    Schebalkin, T
    Thomas, A
    Schänzer, W
    [J]. CHROMATOGRAPHIA, 2005, 62 (7-8) : 435 - 439
  • [9] Sensitive quantification of rifaximin in human plasma by liquid chromatography-tandem mass spectrometry
    Zhang, Xianhua
    Duan, Jingli
    Li, Ke
    Zhou, Liya
    Zhai, Suodi
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 850 (1-2): : 348 - 355
  • [10] Quantification of Clenbuterol in Human Plasma and Urine by Liquid Chromatography-Tandem Mass Spectrometry
    M. Thevis
    T. Schebalkin
    A. Thomas
    W. Schänzer
    [J]. Chromatographia, 2005, 62 : 435 - 439